Evommune, Inc.'s total assets for Q2 2026 were $301.95M, a decrease of -6.36% from the previous quarter. EVMN total liabilities were $24.36M for the fiscal quarter, a 36.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.